Novartis signs stem cell research pact with Intellia – PMLiVE
Fox News |
Novartis signs stem cell research pact with Intellia
PMLiVE Novartis has teamed up with Intellia Therapeutics, which focuses on gene editing and repair, to create treatments from the US biotech's stem cell technology. The deal aims to accelerate the ex vivo ('out of the living') development of new CRISPR/Cas9 … Novartis taps into gene editing for next generation drugs Intellia Therapeutics, Novartis Form Partnership to Develop New Cell Therapies … |
